ALNA News and Press, Allena Pharmaceuticals Inc. From 08/07/19

-- Interim Data from Study 206 Demonstrated Substantial Treatment Effect in Patients with Enteric Hyperoxaluria and Advanced Chronic Kidney Disease, Including Robust Reductions in Both Urine and Plasma Oxalate -- -- Closed $10.0 Million Registered Direct Offering, Extending Cash Runwa...

NEWTON, Mass., Aug. 06, 2019 (GLOBE NEWSWIRE) -- Allena Pharmaceuticals, Inc. (NASDAQ: ALNA), a late-stage, biopharmaceutical company dedicated to developing and commercializing first-in-class, oral enzyme therapeutics to treat patients with rare and severe metabolic and kidney disorders, t...

Allena ( ALNA ) caught my attention as a potential beneficiary of the recent executive order focusing attention on improving outcomes in instances of severe kidney disease. After review, I see a glimpse of hope in its strategy as I outline below. For the time being, I am taking a pass on thi...

Allena Pharmaceuticals (NASDAQ: ALNA ) has entered into a securities purchase agreement for the purchase and sale of 2,632,092 common shares, at a price of $3.80/share, in a registered direct offering, for gross proceeds of ~$10M. More news on: Allena Pharmaceuticals, Inc., Healthca...

NEWTON, Mass., June 27, 2019 (GLOBE NEWSWIRE) -- Allena Pharmaceuticals, Inc. (NASDAQ: ALNA), a late-stage, biopharmaceutical company dedicated to developing and commercializing first-in-class, oral enzyme therapeutics to treat patients with rare and severe metabolic and kidney disorders, t...

NEWTON, Mass., June 21, 2019 (GLOBE NEWSWIRE) -- Allena Pharmaceuticals, Inc. (NASDAQ: ALNA), a late-stage, biopharmaceutical company dedicated to developing and commercializing first-in-class, oral enzyme therapeutics to treat patients with rare and severe metabolic and kidney disorders, t...

Gainers: ALNA   +8.4% . AOBC   +7.7% . AHT   +5.0% . ORCL   +3.7% . TCF   +2.0% . More news on: Allena Pharmaceuticals, Inc., American Outdoor Brands Corporation, Ashford Hospitality Trust, Inc., Stocks on the move, , News on ETFs Read more ...

The following slide deck was published by Allena Pharmaceuticals, Inc. in conjunction with this Read more ...

Gainers:  ReWalk Robotics (NASDAQ: RWLK ) +126% . Genocea Biosciences (NASDAQ: GNCA ) +14% . Dean Foods (NYSE: DF ) +13% . RAVE Restaurant Group (NASDAQ: RAVE ) +11% . Medley Management (NYSE: MDLY ) +10% . Neon Therapeutics (NASDAQ: NTGN ) +10% . Allena Pharmaceuticals (NASDAQ:...

-- Substantial Treatment Effect Observed in Patients with Enteric Hyperoxaluria, Including Robust Reductions in Both Urine and Plasma Oxalate – -- Reloxaliase Well-Tolerated Over 12 Weeks of Dosing -- -- Detailed Results to be Presented at OHF International Hyperoxaluria Worksho...